Join us at this seminar
Dr. Edward Xu Han joined Bruker Cellular Analysis (formally IsoPlexis and Berkeley Lights) in 2020 and works on the product management team focusing on single immune cell functional response applications on IsoSpark/IsoLight and Beacon platforms. He obtained his PhD in Biomedical Engineering from Yale University under the mentorship of Dr. Laura Niklason. His research interests include immunology, oncology, drug development, and tissue engineering.
Dr. Padmapriya Sathiyanathan is Senior Scientist at the Cell Fate Engineering and Therapeutics Lab, IMCB, working on donor/ source selection, cell isolation strategies for stem cell manufacturing and reprogramming under the STAMP programme. Priya received her B.Sc. from NTU and was awarded the A*STAR Graduate Scholarship to pursue her doctoral degree there. She then joined the Glycotherapeutics group at IMB where her research identified an innovative donor selection strategy for stem cells. She later moved to GIS, gaining experience in diagnostic assay development before joining IMCB.
What to expect
| 09:30 - 10:00 | Registration |
| 10:00 - 10:10 |
Opening Address Dr. Jonathan Yuin-Han LOH, IMCB, A*STAR |
| 10:10 - 11:00 |
Revolutionizing Functional Immune Cell Screening and Therapy Development by Single Cell Technologies Dr. Edward Xu Han, Bruker Cellular Analysis |
| 11:00 - 11:20 |
Leveraging on Optofluidic Technology to Expand, Screen and Evaluate MSCs Dr. Padmapriya Sathiyanathan, IMCB, A*STAR |
| 11:20 - 12:00 | Discussion and Poster Session |